Literature DB >> 12485848

The F-actin content of multiple myeloma cells as a measure of their migration.

Eline Menu1, Filip Braet, Maarten Timmers, Ivan Van Riet, Ben Van Camp, Karin Vanderkerken.   

Abstract

One of the main characteristics of multiple myeloma (MM) cells is their specific homing and growth in the bone marrow (BM). For their homing, MM cells need chemotactic signals to be attracted towards the BM and to be activated. Profound knowledge of the different chemokines for MM cells and their signal transduction pathways is necessary to interfere in this process. We studied here an extra possible tool for the investigation of the different chemokines and their pathways. The 5T experimental mouse model was used to investigate the migration of MM cells towards BM stromal cells. We studied the changes of the F-actin content in the 5TMM cells in the presence of BM stromal cell conditioned medium and we correlated this with their migratory capacity. F-actin became polarized when the cells were migrating, in contrast to nonmigrating cells. This polarization could not only be seen by fluorescence and confocal laser scanning microscopy, but also could be quantified by fluorometry and flow cytometry. The correlation between the F-actin content of the MM cells and their migration capacity thus makes its quantification a useful tool in studying their migratory behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12485848     DOI: 10.1111/j.1749-6632.2002.tb04620.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Assessing the cytoskeletal system and its elements in C6 glioma cells and astrocytes by atomic force microscopy.

Authors:  Dexiang Zhou; Xiaodan Jiang; Ruxiang Xu; Yingqian Cai; Jiliang Hu; Gang Xu; Yuxi Zou; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-03-04       Impact factor: 5.046

2.  β-Actin is a downstream effector of the PI3K/AKT signaling pathway in myeloma cells.

Authors:  Yen-Peng Ho; Chi-Wei Kuo; Yuan-Tong Hsu; Yu-Shan Huang; Li-Ping Yew; Wei-Feng Huang; Kuo-Chih Lin; Jung-Hsin Hsu
Journal:  Mol Cell Biochem       Date:  2010-11-11       Impact factor: 3.396

3.  Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Authors:  Jo Caers; Dirk Hose; Ine Kuipers; Tomas Jan Bos; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Hartmut Goldschmidt; Ben Van Camp; Bernard Klein; Karin Vanderkerken
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

4.  DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.

Authors:  V Ullmannova-Benson; M Guan; X Zhou; V Tripathi; X-Y Yang; D B Zimonjic; N C Popescu
Journal:  Leukemia       Date:  2008-10-16       Impact factor: 11.528

5.  Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.

Authors:  Arturo Aguilar-Rojas; Maira Huerta-Reyes; Guadalupe Maya-Núñez; Fabián Arechavaleta-Velásco; P Michael Conn; Alfredo Ulloa-Aguirre; Jesús Valdés
Journal:  BMC Cancer       Date:  2012-11-23       Impact factor: 4.430

6.  Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.

Authors:  E Menu; R Kooijman; E Van Valckenborgh; K Asosingh; M Bakkus; B Van Camp; K Vanderkerken
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.